galantamine has been researched along with Liver Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aerssens, J; Armstrong, M; Piotrovsky, V; Van Osselaer, N; Van Peer, A | 1 |
| Iyer, GR; Truyen, L; Verhaeghe, T; Zhao, Q | 1 |
2 other study(ies) available for galantamine and Liver Dysfunction
| Article | Year |
|---|---|
Galantamine population pharmacokinetics in patients with Alzheimer's disease: modeling and simulations.
Topics: Adult; Aged; Algorithms; Alzheimer Disease; Bayes Theorem; Cholinesterase Inhibitors; Clinical Trials as Topic; Computer Simulation; Dose-Response Relationship, Drug; Female; Galantamine; Humans; Liver Diseases; Male; Middle Aged; Models, Biological; Population; Reproducibility of Results; Sex Characteristics; Software | 2003 |
Pharmacokinetics and safety of galantamine in subjects with hepatic impairment and healthy volunteers.
Topics: Adolescent; Adult; Aged; Alzheimer Disease; Analysis of Variance; Area Under Curve; Cholinesterase Inhibitors; Female; Galantamine; Humans; Liver Diseases; Male; Middle Aged; Protein Binding; Statistics, Nonparametric | 2002 |